Authors
Latest:
E-Cigarettes and Vaping: Another Cardiovascular Threat in Disguise?Since its introduction to the US market in 2003, questions have risen as to the safety, long-term consequences, and risk of cardiovascular detriments that e-cigarettes pose to users.
Latest:
Health Information Technology: Facilitating an Evolution in Health CareThe use of health information technology empowers pharmacists to provide enhanced care by harnessing a wealth of actionable information.
Latest:
The Impact of COVID-19 on Recent Pharmacy School GraduatesPharmacy students, particularly the graduating class of 2020, have been uniquely affected by the coronavirus disease 2019 (COVID-19) pandemic.
Latest:
The Beginning of a MovementIf independents have any chance of survival, we need to get into the game ourselves and teach the public what they don't know about PBMs.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
The Changing Clinical Assessment: An Overview and Next-Level ChallengesThe clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.
Latest:
Costs Associated With Second-Line Therapies for Lung CancerErlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.
Latest:
Evaluating the Efficacy of Adjunctive Therapies Used to Treat COVID-19: The Role of Famotidine, Melatonin, and ThiamineH2-receptor antagonists, melatonin, and thiamine are some of the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.
Latest:
PQA Offers New CE Course on HIV Medication Use QualityPQA course provides an overview of how to build the best HIV treatment regimen and assess treatment outcomes.
Latest:
OTC, Prescription Drug Abuse Increasing Among AdolescentsNeighborhood pharmacists can provide support and information.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Latest:
Is Pharmacy Going Green?Pharmacists are concerned about the proper disposal of medical waste, but is enough being done to be truly sustainable and green?
Latest:
Vaccine Collaboration: The Importance of Immunization PartnershipsVaccinations are among the most important preventive measures universally recommended by health authorities today.
Latest:
Droxidopa: Managing Neurogenic HypotensionThough clinically significant, NOH has had few treatment options.
Latest:
The Impact of 'Superutilizers' on Pharmacy SpendingPatients with multiple comorbid conditions siphon off a disproportionate share of health care dollars.
Latest:
A closer look at new FDA actionsMs. Domenici and Dr. Patel are both pharmacists at Brigham and Women's Hospital, Boston, Mass. Ms. Aiello is a sixth-year PharmD candidate from Massachusetts College of Pharmacy currently on clinical clerkship in the Investigational Drug Service at Brigham and Women's Hospital.
Latest:
Therapeutic and Subtherapeutic Dosing of Pregabalin: Medication Adherence, Healthcare Resource Utilization, and CostsTherapeutic and subtherapeutic doses of pregabalin were compared to ascertain differences in adherence, healthcare resource use, and cost between the cohorts.
Latest:
Punitive Damages Are Awarded Against Nursing HomeUnauthorized change in medication Is the subject of a case involving the death of an elderly patient.
Latest:
Evaluating Amantadine as a Potential Treatment for COVID-19Amantadine, a treatment that was originally used as an agent against influenza A, lost efficacy due to viral resistance.
Latest:
Free Drug Starter Programs Are Not All AlikeAlthough free drug starter programs are commonplace in the specialty pharmacy space, they vary widely in the marketplace.
Latest:
Chemotherapy and ObesityWhen giving antineoplastics to obese and morbidly obese patients, clinicians must be careful not to under- or overdose.
